If he or she needs medication then an SU that is nonrenally excreted could be tried, but many patients on dialysis need insulin.
Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback